NCR1 and metastatic prostate carcinoma: Moreover, previous studies showed that the expression of NKp46 was positively associated with overall survival in patients with metastatic prostate cancer (Pasero et al., 2015) and with acute myeloid leukemia (Fauriat et al., 2007).